Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets
Publications
Télécharger-
2025Intra-tumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ DC1 infiltration and activates anti-tumor immunity, Biorxiv Preprint.
-
2025The Rab32 small GTPase is required for efficient cross-priming of CD8+ T cells against cell-associated antigens by XCR1+ type 1 DCs in vivo, Biorxiv - Preprint Article.
-
2025XCR1+ and IRF4+ migratory dendritic cells cooperate for the cross-priming of intratumoral CD8+ T cells with a tissue-resident memory phenotype, Research Square - Preprint Article.
-
2024Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors., Nat Commun 2024 Mar; 15(1): 2280.
-
2023FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis., Cell Rep Med 2023 Dec; 4(12): 101256.
-
2023Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche., Nat Cell Biol 2023 Dec; 25(12): 1736-1745.
-
2023Dendritic cell type 3 arises from Ly6C+ monocyte-dendritic cell progenitors., Immunity 2023 Aug; 56(8): 1761-1777.e6.
-
2023In Vitro Generation of Murine Bone Marrow-Derived Dendritic Cells., Methods Mol Biol 2023 ; 2618(): 83-92.
-
2023In Vitro Generation of Human Dendritic Cell Subsets from CD34+ Cord Blood Progenitors., Methods Mol Biol 2023 ; 2618(): 121-132.
-
2022Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer., Cell 2022 Mar; 185(7): 1189-1207.e25.
-
+Voir la liste complète de publications